{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:27:51Z","timestamp":1791332871334,"version":"4.3.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7053","license":[{"start":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T00:00:00Z","timestamp":1124236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T00:00:00Z","timestamp":1124236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2005,8,18]]},"DOI":"10.1038\/nature04076","type":"journal-article","created":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T17:07:46Z","timestamp":1124298466000},"page":"930-932","source":"Crossref","is-referenced-by-count":183,"title":["Unscrambling hepatitis C virus\u2013host interactions"],"prefix":"10.1038","volume":"436","author":[{"given":"Francis V.","family":"Chisari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,8,17]]},"reference":[{"key":"BFnature04076_CR1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","volume":"36","author":"JH Hoofnagle","year":"2002","unstructured":"Hoofnagle, J. H. Course and outcome of hepatitis C. Hepatology 36, S21\u2013S29 (2002).","journal-title":"Hepatology"},{"key":"BFnature04076_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1055\/s-2000-9505","volume":"20","author":"HJ Alter","year":"2000","unstructured":"Alter, H. J. & Seeff, L. B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis. 20, 17\u201335 (2000).","journal-title":"Semin. Liver Dis."},{"key":"BFnature04076_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00042737-199604000-00005","volume":"8","author":"MJ Alter","year":"1996","unstructured":"Alter, M. J. Epidemiology of hepatitis C. Eur. J. Gastroenterol. Hepatol. 8, 319\u2013323 (1996).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnature04076_CR4","doi-asserted-by":"publisher","first-page":"62S","DOI":"10.1002\/hep.510260711","volume":"26","author":"MJ Alter","year":"1997","unstructured":"Alter, M. J. Epidemiology of hepatitis C. Hepatology 26, 62S\u201365S (1997).","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"BFnature04076_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0168-8278(99)80381-X","volume":"31","author":"MJ Alter","year":"1999","unstructured":"Alter, M. J. Hepatitis C virus infection in the United States. J. Hepatol. 31 (Suppl. 1), 88\u201391 (1999).","journal-title":"J. Hepatol."},{"key":"BFnature04076_CR6","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1002\/hep.1840360712","volume":"36","author":"MJ Alter","year":"2002","unstructured":"Alter, M. J. Prevention of spread of hepatitis C. Hepatology 36, S93\u2013S98 (2002).","journal-title":"Hepatology"},{"key":"BFnature04076_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1006\/pmed.1998.0418","volume":"28","author":"A Spaulding","year":"1999","unstructured":"Spaulding, A., Greene, C., Davidson, K., Schneidermann, M. & Rich, J. Hepatitis C in state correctional facilities. Prev. Med. 28, 92\u2013100 (1999).","journal-title":"Prev. Med."},{"issue":"Suppl. 1","key":"BFnature04076_CR8","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1086\/313842","volume":"30","author":"MS Sulkowski","year":"2000","unstructured":"Sulkowski, M. S., Mast, E. E., Seeff, L. B. & Thomas, D. L. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 30 (Suppl. 1), S77\u2013S84 (2000).","journal-title":"Clin. Infect. Dis."},{"key":"BFnature04076_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.2523562","volume":"244","author":"QL Choo","year":"1989","unstructured":"Choo, Q. L. et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359\u2013362 (1989).","journal-title":"Science"},{"key":"BFnature04076_CR10","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1128\/JVI.77.5.2801-2806.2003","volume":"77","author":"P Sarnow","year":"2003","unstructured":"Sarnow, P. Viral internal ribosome entry site elements: novel ribosome\u2013RNA complexes and roles in viral pathogenesis. J. Virol. 77, 2801\u20132806 (2003).","journal-title":"J. Virol."},{"key":"BFnature04076_CR11","first-page":"11","volume":"24","author":"V Lohmann","year":"1996","unstructured":"Lohmann, V., Koch, J. O. & Bartenschlager, R. Processing pathways of the hepatitis C virus proteins. J. Hepatol. 24, 11\u201319 (1996).","journal-title":"J. Hepatol."},{"key":"BFnature04076_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep.20032","volume":"39","author":"F Penin","year":"2004","unstructured":"Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D. & Pawlotsky, J. M. Structural biology of hepatitis C virus. Hepatology 39, 5\u201319 (2004).","journal-title":"Hepatology"},{"key":"BFnature04076_CR13","doi-asserted-by":"publisher","first-page":"13278","DOI":"10.1128\/JVI.78.23.13278-13284.2004","volume":"78","author":"D Moradpour","year":"2004","unstructured":"Moradpour, D. et al. Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J. Virol. 78, 13278\u201313284 (2004).","journal-title":"J. Virol."},{"key":"BFnature04076_CR14","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","volume":"14","author":"CE Samuel","year":"2001","unstructured":"Samuel, C. E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778\u2013809 (2001).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFnature04076_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ni1087","volume":"5","author":"M Yoneyama","year":"2004","unstructured":"Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 5, 730\u2013737 (2004).","journal-title":"Nature Immunol."},{"key":"BFnature04076_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrd942","volume":"1","author":"R Bartenschlager","year":"2002","unstructured":"Bartenschlager, R. Hepatitis C virus replicons: potential role for drug development. Nature Rev. Drug Discov. 1, 911\u2013916 (2002).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnature04076_CR17","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1073\/pnas.0503596102","volume":"102","author":"J Zhong","year":"2005","unstructured":"Zhong, J. et al. Robust hepatitis C virus infection in vitro. Proc. Natl Acad. Sci. USA 102, 9294\u20139299 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature04076_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1126\/science.1114016","volume":"309","author":"BD Lindenbach","year":"2005","unstructured":"Lindenbach, B. D. et al. Complete replication of hepatitis C virus in cell culture. Science 309, 623\u2013626 (2005).","journal-title":"Science"},{"key":"BFnature04076_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"T Wakita","year":"2005","unstructured":"Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Med. 11, 791\u2013796 (2005).","journal-title":"Nature Med."},{"key":"BFnature04076_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/jmv.1055","volume":"64","author":"T Kato","year":"2001","unstructured":"Kato, T. et al. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J. Med. Virol. 64, 334\u2013339 (2001).","journal-title":"J. Med. Virol."},{"key":"BFnature04076_CR21","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1053\/j.gastro.2003.09.023","volume":"125","author":"T Kato","year":"2003","unstructured":"Kato, T. et al. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808\u20131817 (2003).","journal-title":"Gastroenterology"},{"key":"BFnature04076_CR22","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","volume":"79","author":"SF Wieland","year":"2005","unstructured":"Wieland, S. F. & Chisari, F. V. Stealth and cunning: hepatitis B and hepatitis C. J. Virol. 79, 9369\u20139380 (2005).","journal-title":"J. Virol."},{"key":"BFnature04076_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","volume":"5","author":"B Rehermann","year":"2005","unstructured":"Rehermann, B. & Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Rev. Immunol. 5, 215\u2013229 (2005).","journal-title":"Nature Rev. Immunol."},{"key":"BFnature04076_CR24","doi-asserted-by":"publisher","first-page":"13779","DOI":"10.1128\/JVI.78.24.13779-13792.2004","volume":"78","author":"CB Bigger","year":"2004","unstructured":"Bigger, C. B. et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J. Virol. 78, 13779\u201313792 (2004).","journal-title":"J. Virol."},{"key":"BFnature04076_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev.micro.58.030603.123836","volume":"58","author":"NH Shoukry","year":"2004","unstructured":"Shoukry, N. H., Cawthon, A. G. & Walker, C. M. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu. Rev. Microbiol. 58, 391\u2013424 (2004).","journal-title":"Annu. Rev. Microbiol."},{"key":"BFnature04076_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1126\/science.282.5386.103","volume":"282","author":"AU Neumann","year":"1998","unstructured":"Neumann, A. U. et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-\u03b1 therapy. Science 282, 103\u2013107 (1998).","journal-title":"Science"},{"key":"BFnature04076_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.2001.1316","volume":"293","author":"RE Lanford","year":"2002","unstructured":"Lanford, R. E. & Bigger, C. Advances in model systems for hepatitis C virus research. Virology 293, 1\u20139 (2002).","journal-title":"Virology"},{"key":"BFnature04076_CR28","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.1082604","volume":"300","author":"E Foy","year":"2003","unstructured":"Foy, E. et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300, 1145\u20131148 (2003).","journal-title":"Science"},{"key":"BFnature04076_CR29","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1073\/pnas.0408707102","volume":"102","author":"E Foy","year":"2005","unstructured":"Foy, E. et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl Acad. Sci. USA 102, 2986\u20132991 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature04076_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0166-3542(01)00180-2","volume":"52","author":"MU Mondelli","year":"2001","unstructured":"Mondelli, M. U. et al. Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain? Antiviral Res. 52, 153\u2013159 (2001).","journal-title":"Antiviral Res."},{"key":"BFnature04076_CR31","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1084\/jem.20050808","volume":"201","author":"DG Bowen","year":"2005","unstructured":"Bowen, D. G. & Walker, C. M. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J. Exp. Med. 201, 1709\u20131714 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnature04076_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20040638","volume":"200","author":"D Meyer-Olson","year":"2004","unstructured":"Meyer-Olson, D. et al. Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J. Exp. Med. 200, 307\u2013319 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnature04076_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1089-3261(02)00077-6","volume":"7","author":"JG McHutchison","year":"2003","unstructured":"McHutchison, J. G. & Fried, M. W. Current therapy for hepatitis C: pegylated interferon and ribavirin. Clin. Liver Dis. 7, 149\u2013161 (2003).","journal-title":"Clin. Liver Dis."},{"key":"BFnature04076_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(03)00088-3","volume":"59","author":"JM Pawlotsky","year":"2003","unstructured":"Pawlotsky, J. M. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res. 59, 1\u201311 (2003).","journal-title":"Antiviral Res."},{"key":"BFnature04076_CR35","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/hep.20119","volume":"39","author":"DB Strader","year":"2004","unstructured":"Strader, D. B., Wright, T., Thomas, D. L. & Seeff, L. B. Diagnosis, management, and treatment of hepatitis C. Hepatology 39, 1147\u20131171 (2004).","journal-title":"Hepatology"},{"key":"BFnature04076_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature02099","volume":"426","author":"D Lamarre","year":"2003","unstructured":"Lamarre, D. et al. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426, 186\u2013189 (2003).","journal-title":"Nature"},{"key":"BFnature04076_CR37","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1053\/jhep.2003.50474","volume":"38","author":"F Nevens","year":"2003","unstructured":"Nevens, F. et al. A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C. Hepatology 38, 1289\u20131296 (2003).","journal-title":"Hepatology"},{"key":"BFnature04076_CR38","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/jvi.68.3.1494-1500.1994","volume":"68","author":"YK Shimizu","year":"1994","unstructured":"Shimizu, Y. K. et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68, 1494\u20131500 (1994).","journal-title":"J. Virol."},{"key":"BFnature04076_CR39","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1053\/jhep.2001.24371","volume":"33","author":"SE Bassett","year":"2001","unstructured":"Bassett, S. E. et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33, 1479\u20131487 (2001).","journal-title":"Hepatology"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature04076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature04076","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature04076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T23:00:23Z","timestamp":1743807623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature04076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,17]]},"references-count":39,"journal-issue":{"issue":"7053","published-print":{"date-parts":[[2005,8,18]]}},"alternative-id":["BFnature04076"],"URL":"https:\/\/doi.org\/10.1038\/nature04076","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,17]]}}}